Latham & Watkins LLP is well-known in the market for handling complex IP transactions, including cross-licensing, collaboration, and joint agreements, as well as due diligence relating to the licensing of IP. The team chiefly handles licenses relating to the life sciences and technology sectors, fielding dedicated teams maintaining close relationships with clients in these spaces. Key members of the team are Christopher Hazuka in San Diego, who advises life sciences companies on agreements and transactions, Aaron Gardner in New York, who focuses on the biotech and nutrition spaces, and Jengeun Jekkie Kim in the Bay Area, who handles licensing and commercial transactions in connection with digital health products and medical devices. Judith Hasko has left the firm.
Legal 500 redaktioneller Kommentar
Auszeichnungen
Mandantenzufriedenheit
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
- 'I was really impressed with Aaron Gardner. Aaron has very comprehensive expertise in life sciences industry, so even though we worked on a licensing deal, his M&A experiences came in really handy on complex issues. He is a senior partner but can still draft on the fly (to the details of flawless section references and formatting) while negotiating and providing high-level strategic advice on the deal. Aaron is absolutely one of the top advisors.'
Kernmandanten
- Shape Therapeutics
- Sonoma Biotherapeutics
- Scleroderma Research Foundation
- CytomX
- 4D Molecular Therapeutics (4DMT)
- Endeavor BioMedicines
- Sanofi
- Erasca, Inc.
- Nielsen BioSciences, Inc.
- Zentalis Pharmaceuticals, Inc.
Anwält*innen
Partner*innen der nächsten Generation
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Praxisleitung
Judith Hasko
Weitere Kernanwält*innen
Christopher Hazuka; Aaron Gardner; Jungeun Jekkie Kim